We found new metastasis in 23 patients (liver 11, lung 5, peritoneum 6, bone 1). There is no difference in DFS between II and IIL (P =0.064). But recurrence more frequently appeared with lymatic invasion group. There is no difference in DFS between IIL and III (P = 0.083). But cancer stage had not effect to recurrence (P = 0.153). In IIL patients, statistically difference did not be shown between oral and intravenous chemotherapy group (P = 0.500). But chemotherapy completion group had higher DFS (P = 0.001). Conclusion: Between II and IIL, DFS did not have difference but low P-value. In consideration of correlation analysis result and DFS between IIL and III, we think their prognosis is not same and completion of chemotherapy influence on good outcome in stage II with lymphatic invasion colon cancer.

